[{"Assets_0_FY_USD":13870100000.0,"CIK":"1585364","CommonStockDividendsPerShareDeclared_4_FY_USD":0.58,"CommonStockSharesConverted_0_FY_shares":143400000.0,"Country":"United States","EarningsPerShareBasic_1_FY_USD":-9.48,"EarningsPerShareBasic_4_FY_USD":-28.01,"EarningsPerShareDiluted_1_FY_USD":-9.48,"EarningsPerShareDiluted_4_FY_USD":-28.01,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":654900000.0,"NetIncomeLossConverted_1_FY_USD":-1359100000.0,"NetIncomeLossConverted_4_FY_USD":-4012800000.0,"OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_FY_USD":1331200000.0,"RevenuesConverted_4_FY_USD":5280600000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_FY_USD":5957600000.0,"StockholdersEquity_0_FY_USD":5958100000.0,"Ticker":"PRGO_2","WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":143400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":143300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":143400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":143300000.0,"filed":"20170522","footnote":"nan","form":"10-K","fp":"FY","fy":"2016.0","name":"PERRIGO CO PLC","period":"20161231","qtrs":"0","uom":"USD"}]